Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Poly-ADP-ribosylation is a post-translational modification performed by poly(ADP-ribose) polymerases (
PARP
), involved in many diverse cellular functions including DNA repair, transcription, and long-term potentiation. Paradoxically,
PARP
over-activation under pathologic conditions including traumatic brain injury (TBI) results in cell death. We previously demonstrated that intra-mitochondrial poly-ADP-ribosylation occurs following excitotoxic and oxidative injury in vitro. Here we sought to identify mitochondrial proteins modified by poly-ADP-ribosylation after TBI in vivo. Poly-ADP-ribosylation within mitochondria from injured brain after experimental TBI in rats was first verified using western blot and immuno-electron microscopy. Poly-ADP-ribosylated mitochondrial proteins identified using a targeted proteomic approach included voltage-dependent anion channel-1,
mitofilin
, mitochondrial stress proteins, and the electron transport chain components F1F0 ATPase, cytochrome c oxidase, and cytochrome c reductase. To examine the functional consequences of mitochondrial poly-ADP-ribosylation, isolated rat brain mitochondria were exposed to conditions of nitrosative stress known to activate
PARP
.
PARP
activation-induced reductions in State 3 respiration were prevented by the
PARP-1
inhibitor 5-iodo-6-amino-1,2-benzopyrone or exogenous poly(ADP-ribose) glycohydrolase. As the effects of
PARP
activation on mitochondrial respiration appear regulated by poly(ADP-ribose) glycohydrolase, a direct effect of poly-ADP-ribosylation on electron transport chain function is suggested. These findings may be of relevance to TBI and other diseases where mitochondrial dysfunction occurs.
...
PMID:Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury. 1799 29
Poly(ADP-ribose)polymerase-1 (
PARP-1
) is a predominantly nuclear enzyme that exerts numerous functions in cellular physiology and pathology, from maintenance of DNA stability to transcriptional regulation. Through a proteomic analysis of
PARP-1
co-immunoprecipitation complexes, we identified
Mitofilin
, a mitochondrial protein, as a new
PARP-1
interactor. This result prompted us to further investigate the presence and the role of the enzyme in mitochondria. Using laser confocal microscopy and Western blot analysis of purified mitochondria, we demonstrated the mitochondrial localization of a fraction of
PARP-1
. Further, the effects of overexpressing or down-regulating
Mitofilin
showed that this protein promotes and is required for
PARP-1
mitochondrial localization. We also report several lines of evidence suggesting that intramitochondrial
PARP-1
plays a role in mitochondrial DNA (mtDNA) damage signaling and/or repair. First, we show that
PARP-1
binds to different regions throughout the mtDNA. Moreover, we demonstrated that the depletion of either
PARP-1
or
Mitofilin
, which abrogates the mitochondrial localization of the enzyme, leads to the accumulation of mtDNA damage. Finally, we show that DNA ligase III, known to be required for mtDNA repair, participates in a
PARP-1
-containing complex bound to mtDNA. This work highlights a new environment for
PARP-1
, opening the possibility that at least some of the nuclear functions of the enzyme can be also extended to mtDNA metabolism.
...
PMID:Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. 1976 72
Mitofilin
is an inner membrane protein that has been defined as a mitochondria-shaping protein in controlling and maintaining mitochondrial cristae structure and remodeling. We determined the role of
mitofilin
in cell survival by investigating the mechanism underlying
mitofilin
knockdown-induced cell death by apoptosis. Cultured H9c2 myoblasts and HEK 293 cells were treated with
mitofilin
siRNA or scrambled siRNA for 24 h. Cell death (apoptosis), caspase 3 activity and cell cycle phases were assessed by flow cytometry, while cytochrome c release and intracellular ATP production were measured by ELISA.
Mitofilin
, apoptosis-inducing factor (AIF) and poly(ADP-ribose) polymerase (
PARP
) expression were measured by Western blot analysis and calpain activity was assessed using a calpain activity kit. Mitochondrial images were taken using electron microscopy. We found that
mitofilin
knockdown increases apoptosis mainly via activation of the AIF-
PARP
pathway leading to nuclear fragmentation that is correlated with S phase arrest of the cell cycle. Knockdown of
mitofilin
also led to mitochondrial swelling and damage of cristae that is associated with the increase in reactive oxygen species production and mitochondrial calpain activity, as well as a marked decrease in intracellular ATP production and mitochondrial membrane potential. Together, these results indicate that
mitofilin
knockdown by siRNA increases calpain activity that presumably leads to mitochondrial structural degradation resulting in a critical reduction of mitochondrial function that is responsible for the increase in cell death by apoptosis via an AIF-
PARP
mechanism and associated with nuclear fragmentation, and S phase arrest of the cell cycle.
...
PMID:Mitochondrial inner membrane protein (mitofilin) knockdown induces cell death by apoptosis via an AIF-PARP-dependent mechanism and cell cycle arrest. 2948 84